These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7530772

  • 1. Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease.
    Carsons S, Clausen H, Wolf J.
    J Rheumatol; 1994 Oct; 21(10):1888-91. PubMed ID: 7530772
    [Abstract] [Full Text] [Related]

  • 2. Enhanced expression of a peanut agglutinin reactive O linked oligosaccharide on fibronectins from the synovial fluid of patients with rheumatic disease: quantitation, domain localization, and functional significance.
    Carsons S.
    J Rheumatol; 2002 May; 29(5):896-902. PubMed ID: 12022346
    [Abstract] [Full Text] [Related]

  • 3. Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.
    Carsons S, Lavietes BB, Slomiany A, Diamond HS, Berkowitz E.
    J Clin Invest; 1987 Nov; 80(5):1342-9. PubMed ID: 3680500
    [Abstract] [Full Text] [Related]

  • 4. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis.
    Chevalier X, Claudepierre P, Groult N, Zardi L, Hornebeck W.
    J Rheumatol; 1996 Jun; 23(6):1022-30. PubMed ID: 8782135
    [Abstract] [Full Text] [Related]

  • 5. Detection and quantitation of stem cell factor (kit ligand) in the synovial fluid of patients with rheumatic disease.
    Carsons SE, Santiago-Schwarz F, Diola C.
    J Rheumatol; 2000 Dec; 27(12):2798-800. PubMed ID: 11128666
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression.
    Przybysz M, Borysewicz K, Szechinski J, Katnik-Prastowska I.
    Rheumatology (Oxford); 2007 Jul; 46(7):1071-5. PubMed ID: 17459959
    [Abstract] [Full Text] [Related]

  • 9. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
    Mandel U, Hamilton Therkildsen M, Reibel J, Sweeney B, Matsuura H, Hakomori S, Dabelsteen E, Clausen H.
    APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
    [Abstract] [Full Text] [Related]

  • 10. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U, Gaggero B, Reibel J, Therkildsen MH, Dabelsteen E, Clausen H.
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE.
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [Abstract] [Full Text] [Related]

  • 13. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.
    Peters JH, Carsons S, Yoshida M, Ko F, McDougall S, Loredo GA, Hahn TJ.
    Arthritis Res Ther; 2003 May; 5(6):R329-39. PubMed ID: 14680507
    [Abstract] [Full Text] [Related]

  • 14. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
    Schedel J, Distler O, Woenckhaus M, Gay RE, Simmen B, Michel BA, Müller-Ladner U, Gay S.
    Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
    Matsuura H, Hakomori S.
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium.
    Müller-Ladner U, Elices MJ, Kriegsmann JB, Strahl D, Gay RE, Firestein GS, Gay S.
    J Rheumatol; 1997 Oct; 24(10):1873-80. PubMed ID: 9330926
    [Abstract] [Full Text] [Related]

  • 19. Fibronectin fragments in osteoarthritic synovial fluid.
    Xie DL, Meyers R, Homandberg GA.
    J Rheumatol; 1992 Sep; 19(9):1448-52. PubMed ID: 1433014
    [Abstract] [Full Text] [Related]

  • 20. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
    Hashimoto H, Tanaka M, Suda T, Tomita T, Hayashida K, Takeuchi E, Kaneko M, Takano H, Nagata S, Ochi T.
    Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.